Analysis of relapse-free and overall survival in oncoplastic and organ-preserving surgeries in patients with breast cancer

O. G. Babayeva, S. V. Sidorov, S. Novikov, T. E. Kvon, K. E. Shevchenko
{"title":"Analysis of relapse-free and overall survival in oncoplastic and organ-preserving surgeries in patients with breast cancer","authors":"O. G. Babayeva, S. V. Sidorov, S. Novikov, T. E. Kvon, K. E. Shevchenko","doi":"10.17709/2410-1893-2021-8-4-6","DOIUrl":null,"url":null,"abstract":"Purpose of the study. To study the results of relapse-free and overall survival during organ- preserving and oncoplastic surgeries in patients with breast cancer.Materials and methods. A prospective clinical study of 84 patients was carried out in the mammology department on the basis of GBUZ NSO \"GKB № 1\". The first group of patients (40 patients) underwent OPR with ALAE - oncoplastic resection of the mammary gland with axillary lymphadenectomy. The second group (44 patients) WSR with ALAE - wide sector resection of the mammary gland with axillary lymphadenectomy.During the study, the patients were comparable in age, stage (TNM), histological type, and morphogenetic data. The survival rate was studied by the number of local relapses and distant metastases, using laboratory and instrumental studies. The quality of life was assessed on the basis of anamnestic data (Karnofsky index, ECOG scale).Results. In the first group of patients, disease-free and overall survival rate was 97.5 %. At the same time, a local recurrence was found in a patient with a triple negative tumor type, distant metastases to the lungs in a patient with a HER2/neu-positive type. In the second group, relapse-free survival was 95.4 %, overall - 97.7 %. Relapses in two patients with HER2/neu-positive type, metastases to the lungs in a patient with triple negative type.Conclusion. Relapse-free survival rates are 2.1 % higher in group I patients who underwent oncoplastic resection with axillary lymphadenectomy. And the indicators of overall survival in patients of both groups do not differ relatively.","PeriodicalId":334809,"journal":{"name":"Research and Practical Medicine Journal","volume":"15 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Research and Practical Medicine Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17709/2410-1893-2021-8-4-6","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose of the study. To study the results of relapse-free and overall survival during organ- preserving and oncoplastic surgeries in patients with breast cancer.Materials and methods. A prospective clinical study of 84 patients was carried out in the mammology department on the basis of GBUZ NSO "GKB № 1". The first group of patients (40 patients) underwent OPR with ALAE - oncoplastic resection of the mammary gland with axillary lymphadenectomy. The second group (44 patients) WSR with ALAE - wide sector resection of the mammary gland with axillary lymphadenectomy.During the study, the patients were comparable in age, stage (TNM), histological type, and morphogenetic data. The survival rate was studied by the number of local relapses and distant metastases, using laboratory and instrumental studies. The quality of life was assessed on the basis of anamnestic data (Karnofsky index, ECOG scale).Results. In the first group of patients, disease-free and overall survival rate was 97.5 %. At the same time, a local recurrence was found in a patient with a triple negative tumor type, distant metastases to the lungs in a patient with a HER2/neu-positive type. In the second group, relapse-free survival was 95.4 %, overall - 97.7 %. Relapses in two patients with HER2/neu-positive type, metastases to the lungs in a patient with triple negative type.Conclusion. Relapse-free survival rates are 2.1 % higher in group I patients who underwent oncoplastic resection with axillary lymphadenectomy. And the indicators of overall survival in patients of both groups do not differ relatively.
乳腺癌肿瘤和器官保留手术的无复发和总生存期分析
研究目的:目的:探讨乳腺癌患者在器官保留和肿瘤整形手术中的无复发生存率和总生存率。材料和方法。基于GBUZ NSO“GKB№1”对乳腺科84例患者进行前瞻性临床研究。第一组患者(40例)行OPR + ALAE -乳腺肿瘤切除术+腋窝淋巴结切除术。第二组(44例)WSR联合ALAE全部门乳腺切除术加腋窝淋巴结切除术。在研究中,患者在年龄,分期(TNM),组织学类型和形态发生数据方面具有可比性。生存率通过局部复发和远处转移的数量来研究,使用实验室和仪器研究。生活质量根据记忆数据(Karnofsky指数,ECOG量表)进行评估。第一组患者无病生存率和总生存率为97.5%。同时,在三阴性肿瘤型患者中发现局部复发,在HER2/新阳性患者中发现远处转移到肺部。第二组无复发生存率为95.4%,总生存率为97.7%。2例HER2/新阳性患者复发,1例三阴性患者肺转移。I组患者行肿瘤切除术加腋窝淋巴结切除术后无复发生存率高2.1%。两组患者总生存指标无相对差异。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信